Table 4.
Quality of life, saliva, and swallowing outcomes.
| Quality of life assessment | Baseline | 3 months | 6 months | Baseline to 3 months | Baseline to 6 months |
|---|---|---|---|---|---|
| Median | Confidence intervals | ||||
| MDADI composite score | 71.6 (N = 10) | 62.1 (N = 9) | 55.8 (N = 5) | −12.6 to 4.2 (N = 9) | −28.4 to 7.4 (N = 5) |
| EORTC QLQ-C30 functional | 76.7 (N = 9) | 72.2 (N = 10) | 71.1 (N = 5) | −14.4 to 4.4 (N = 9) | −17.8 to 20 (N = 5) |
| EORTC QLQ-C30 symptom | 23.1 (N = 9) | 26.9 (N = 10) | 28.1 (N = 5) | −7.7 to 12.8 (N = 9) | −15.4 to 35.9 (N = 5) |
| EORTC QLQ-C30 global | 50 (N = 9) | 54.2 (N = 10) | 58.3 (N = 5) | −20.8 to 16.7 (N = 9) | −25 to 25 (N = 5) |
| XeQoLS | 15 (N = 10) | 16.5 (N = 10) | 18 (N = 5) | −2 to 9.5 (N = 9) | −10 to 16 (N = 5) |
| Xerostomia inventory | 34.5 (N = 10) | 34.5 (N = 10) | 36 (N = 5) | −3 to 5 (N = 5) | −6 to 6 (N = 5) |
| Saliva and swallowing outcomes | |||||
| Unstimulated salivary flow rate | 0.225 ml/min (N = 10) | 0.178 ml/min (N = 10) | 0.192 ml/min (N = 4) | −0.246 to 0.09 (N = 8) | −0.218 to 0.12 (N = 4) |
| DIGEST safety score | 1 (N = 10) | 1 (N = 9) | 2 (N = 5) | −0.5 to 0.5 (N = 9) | 0.0 to 2.0 (N = 5) |
| DIGEST efficiency score | 3 (N = 10) | 3 (N = 9) | 3 (N = 5) | −0.5 to 1.5 (N = 9) | 0.0 to 3.0 (N = 5) |
| DIGEST overall score | 2 (N = 10) | 2 (N = 9) | 3 (N = 5) | 0.0 to 0.5 (N = 9) | 0.0 to 3.0 (N = 5) |
MDADI, MD Anderson Dysphagia Inventory; EORTC, European Organization for Research and Treatment of Cancer; QLQ-C30, Quality of Life Questionnaire; XeQoLS, Xerostomia-Related Quality of Life Scale; DIGEST, Dynamic Imaging Grade of Swallowing Toxicity.